Granzer Regulatory Consulting & Services was founded in 2002 by Ulrich Granzer. Since then, we have helped >1.000 clients world-wide, with a proven record of ensuring client success.
Our staff of experienced consultants comes with backgrounds of having successfully worked for many years in large and small pharma as well as biotech companies and/or regulatory authorities. This wealth of experience and knowledge, across all disciplines required for drug development and regulatory submissions, can now work for you.
No matter if you are an SME or a large pharma company, we can support you in all phases of drug and device development. From defining the right development strategy to submitting your marketing authorisation application, all the way through to approval and beyond.